Preclinical evaluation

Preclinical studies

Progressing from in vitro to in vivo studies can be a critical time for a project. Going too early & generating poor results can kill a project. Delaying too long costs time & money. It is important to plan the right studies and to identify the right CRO.

CBV has experience in achieving this important project milestone across multiple therapeutic areas, with both biologicals & new chemical entities & can provide the guidance you may need.

You are viewing the text version of this site.

To view the full version please install the Adobe Flash Player and ensure your web browser has JavaScript enabled.

Need help? check the requirements page.

Get Flash Player